Our Business Development team is driven by the company's core values: collaboration, innovation, and entrepreneurship. These values guide our efforts to make a meaningful impact on patients' lives. The team's diverse perspectives enhance discussions, while our emphasis on flexibility, creativity, and solution-driven thinking underpins our successful collaborations. We are dedicated to nurturing robust connections that align with partners' needs, all with the ultimate goal of positively affecting patients. Building strong relationships is at the heart of our mission, as we constantly strive to offer innovative solutions to our associates.

Meet Evotec's Business Development Team

We collaborate globally to form partnerships that enable innovation and the delivery of medicines that matter.

headshot of Bernd Mühlenweg
Evotec logo big

Bernd Mühlenweg

SVP, Head of Global Business Development

Evotec logo big

Latest update: October 2025

Biography


Bernd Mühlenweg has more than two decades of experience in senior positions focusing on business and corporate development along with alliance management in the pharma and biotechnology industries. With innovation moving at such a fast pace, he is inspired by the ever changing nature of his role focusing on partnering and licensing of Evotec’s proprietary assets. The continuous learning embedded in experience motivates him to drive forward, together with his team, building sustainable, fruitful, and durable alliances and partnerships to advance innovations in approved medications.

Evotec logo big
Headshot of Guy Rachmuth
RZ Logo Just 220829 RGB color

Guy Rachmuth, PhD

SVP, Global Strategic Business Development & Partnerships

RZ Logo Just 220829 RGB color

Latest update: October 2025

Biography

Guy brings over 20 years of leadership experience in corporate strategy, business development, and commercial execution across the life sciences and healthcare technology sectors. Prior to joining Just – Evotec Biologics, he served as Vice President of Corporate Strategy – Enterprise at IQVIA, following earlier roles as Vice President of Strategy and Corporate Development at IQVIA Laboratories. His career also includes leadership positions at Quintiles, M*Modal (acquired by 3M), and Nucryst Pharmaceuticals (acquired by Smith & Nephew).

Guy is the founder of two AI-driven healthcare technology startups, where he held CEO and CTO roles. He has deep expertise in commercial market expansion, M&A and strategic partnerships.

At Just – Evotec Biologics, Guy leads strategic efforts to expand business revenue across CDMO Services, Products for Sale, Technology Out-licensing, and Continuous Manufacturing Enablement.

Guy holds an M.S. and Ph.D. in Biomedical Engineering from Harvard University, and B.S. in Biomedical Engineering from Boston University.

RZ Logo Just 220829 RGB color

Our Partnering Philosophy

Our focus lies in providing early-stage, preclinical, and cutting-edge treatment candidates, which propel our evolution as a leading biopharmaceutical company in the business-to-business sector. Our commitment to fostering collaboration involves identifying strategic alliances and synergies among various companies while facilitating the efficient exchange of ideas and resources. Right from the outset of our discussions, we engage with our partners in a flexible and transparent manner, grounded in scientific excellence. Our Alliance Management Team further reinforces an atmosphere of trust that fuels successful, enduring partnerships. We take pride in the fact that more than 90% of our business results from repeat collaborations, a testament to our dedication to listening to our partners and tailoring bespoke solutions.

We strive to accelerate our partner’s scientific objectives by leveraging Evotec’s unique expertise across a broad range of collaboration and deal models in the most capital efficient way to ensure mutual long-term success.

We are proud to say that over 90% of our business comes from repeat business. We achieve this by listening to our partners and engaging in the design of customized solutions.

Every one of our collaborative endeavors is meticulously crafted to meet the unique scientific requirements of each program and partner. Our unparalleled flexibility and multi-modal approach empower our BD team to approach challenges creatively and focus on finding solutions.

Establishing a strong rapport with our partners from the outset is paramount, enabling us to maintain alignment and a partner-centric approach. At Evotec, we are committed to forging the right alliances that have the most substantial impact, not only for our partners but also with the well-being of the end patient in mind.

TODO

Partnership Spotlight

Explore our stories of innovation, breakthroughs, and collaborative science that have emerged through our dynamic alliances with partners across diverse domains.

Learn more

Our Upcoming Events

Join us as we build partnerships that last to develop medicines that matter. We hope to meet you at one of the following conferences.

You might be interested in...